StockNews.com Begins Coverage on Calithera Biosciences (NASDAQ:CALA)

StockNews.com began coverage on shares of Calithera Biosciences (NASDAQ:CALA) in a report released on Saturday. The brokerage issued a hold rating on the biotechnology company’s stock.

Calithera Biosciences Stock Performance

CALA opened at $0.01 on Friday. The company’s 50-day simple moving average is $0.01 and its two-hundred day simple moving average is $0.01. Calithera Biosciences has a 52-week low of $0.00 and a 52-week high of $0.12.

About Calithera Biosciences

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.